Articles

Collaboration advances research into childhood cancers

30th September 2014

Collaboration advances research into childhood cancersLouise Bellamy

As September is Childhood Cancer Awareness Month in the UK, it is a good time to highlight the work being done in research and clinical trials, review developments to date,... Read more

UK Prix Galien: New treatment for multidrug-resistant TB

30th September 2014

UK Prix Galien: New treatment for multidrug-resistant TBStaff reporter

This article is the latest in a series investigating some of the shortlisted products in the prestigious UK Prix Galien awards, and their potential impact on health services. Prior to... Read more

Play to learn? Gamification in healthcare

29th September 2014

Play to learn? Gamification in healthcareAshish Khera

Are you ready to 'play to learn'? The latest trend in healthcare is to make this subject fun and hence more engaging and effective for both preventative healthcare and management... Read more

UK Prix Galien: Meningitis vaccine shortlisted

26th September 2014

UK Prix Galien: Meningitis vaccine shortlistedStaff reporter

The finalists in this year's UK Prix Galien awards include a number of candidates which - in addition to impressive clinical credentials - also promise to tackle some important public... Read more

News

Regeneron and Sanofi’s dupilumab delivers in phase IIa for sinusitis

30th September 2014

Regeneron and Sanofi’s dupilumab delivers in phase IIa for sinusitisLinda Banks

Regeneron Pharmaceuticals and Sanofi have announced more positive results for their novel drug dupilumab in the allergic inflammatory arena.Their phase IIa proof-of-concept study of dupilumab, which works by blocking IL-4... Read more

Opdivo to be reviewed in Europe for lung cancer

29th September 2014

Opdivo to be reviewed in Europe for lung cancerAndrew McConaghie

Bristol-Myers Squibb has announced that its new immunotherapy treatment nivolumab has been accepted for review by the EMA for non-small cell lung cancer (NSCLC).The EMA has formally accepted the firm's submission, which puts it in pole... Read more

Daiichi boosts cancer pipeline with $410m Ambit acquisition

29th September 2014

Daiichi boosts cancer pipeline with $410m Ambit acquisitionStaff reporter

Japan's Daiichi Sankyo has agreed a deal to buy Ambit Biosciences of the US for up to $410 million, bringing a new leukaemia candidate into its pipeline.The $15-per-share cash deal... Read more

CHMP gives positive opinion for HIV drug Rezolsta

29th September 2014

CHMP gives positive opinion for HIV drug Rezolsta  Linda Banks

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Rezolsta (darunavir/cobicistat) in combination with other antiretroviral medicinal products... Read more

Audio & Video

Live webinar: Is pharma brand marketing …

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to... View more

Tweetchat: Managing diabetes in the real…

Atlantis Healthcare diabetes Tweetchat


Atlantis Healthcare is working with pharmaphorum to conduct a Tweetchat on the real world challenges patients face in managing... View more

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Probiodrug plans IPO to accelerate Alzheimer's ambitions

Germany's Probiodrug has become the latest European biotech to consider an initial public offering (IPO) as it t... Read more

News

Stunning results for Roche’s Perjeta in extending lives

Trials of Roche's Perjeta show it could help extend the lives of women with advanced breast cancer by over a ... Read more

News

Quality of life for cancer patients highlighted at ESMO

There is an insatiable demand for news of new drugs which promise to prolong the lives of cancer patients, or ev... Read more

News

Pharma winners celebrate at PM Society Digital Media Awards

Novartis beat off Bayer, Boehringer Ingelheim, Genentech (Roche), GlaxoSmithKline and Sanofi to take the firs... Read more

News

Crunch time for Helsinn's cancer support therapy

This is a big week for Swiss pharma company Helsinn as it gets ready to present pivotal data on anamorelin, its ... Read more

News

AZ and Cancer Research UK set up research lab

A joint laboratory for R&D of biological cancer treatments has been announced by MedImmune, the R&D a... Read more

News